Page last updated: 2024-08-24

halofuginone and Carcinoma, Non-Small Cell Lung

halofuginone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ceylan, H; Demiroglu-Zergeroglu, A; Donbaloglu, F; Karadeniz Cerit, K; Odongo, RR; Topal, H; Turhal, G	1

Other Studies

1 other study(ies) available for halofuginone and Carcinoma, Non-Small Cell Lung

Article	Year
Anticarcinogenic effects of halofuginone on lung-derived cancer cells. Cell biology international, 2020, Volume: 44, Issue:9 Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Humans; Lung; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma, Malignant; p38 Mitogen-Activated Protein Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Signal Transduction; STAT3 Transcription Factor	2020

Article

Year

Anticarcinogenic effects of halofuginone on lung-derived cancer cells.

Cell biology international, 2020, Volume: 44, Issue:9

Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Humans; Lung; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma, Malignant; p38 Mitogen-Activated Protein Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Signal Transduction; STAT3 Transcription Factor

2020